Table 3.
Patients with hemoglobin concentrations within 9.5 to 13.0 g/dL
| Interval | Cohort A | Cohort B | Cohort C | Cohort D | Cohort E | Cohort F | Cohort G | Cohort H | Total l | Cohorts With an ESA- Free Interval (D, E, F) | Cohorts Without an ESA- Free Interval (A, B, C, G, H) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weeks 2–13, n |
14 |
15 |
12 |
25 |
15 |
13 |
25 |
29 |
148 |
53 |
95 |
| no. (%) |
9 (64.3) |
12 (80.0) |
9 (75.0) |
21 (84.0) |
11 (73.3) |
11 (84.6) |
20 (80.0) |
18 (62.1) |
111 (75.0) |
43 (81.1) |
68 (71.6) |
| Weeks 14-25, n |
6 |
10 |
10 |
25 |
13 |
13 |
24 |
26 |
127 |
51 |
76 |
| no. (%) | 5 (83.3) | 9 (90.0) | 6 (60.0) | 21 (84.0) | 12 (92.3) | 10 (76.9) | 21 (87.5) | 16 (61.5) | 100 (78.7) | 43 (84.3) | 57 (75.0) |
First row of each set indicates the total number of patients, second row, the number within range and the percentage.